Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, ...

Venous leg ulcers are a preventable and treatable condition, yet hundreds of thousands of people continue to suffer ...

As doubts swirl about President Donald Trump's physical condition, his doctor says "advanced imaging tests" on his ...

Donald Trump’s MRI results are again in the news, which explains the White House’s newly released memo on the president’s ...

RWJBarnabas Health's commitment to enhancing access to care includes a transformative partnership with Rutgers University, including the Rutgers Cancer Institute -- the state's only NCI-designated ...

Harnessing data is essential to improve quality and patient safety, the chief medical and quality officer of CommonSpirit Health says.

President Donald Trump's MRI results reveal normal cardiovascular health as the administration faces increased media scrutiny ...

The 79-year-old president also underwent imaging for abdominal health, and he “remains in excellent overall health,” Trump’s ...

Akura Medical, a Shifamed portfolio company, announced today that it completed the first close of its Series C financing, ...

This article discusses the challenges and nuances involved in using CAUTI and CLABSI rates as performance measures for ...

Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.